Stephen D. Nimer

24.6k total citations · 3 hit papers
239 papers, 14.6k citations indexed

About

Stephen D. Nimer is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Stephen D. Nimer has authored 239 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Hematology, 128 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Stephen D. Nimer's work include Acute Myeloid Leukemia Research (86 papers), Epigenetics and DNA Methylation (35 papers) and Hematopoietic Stem Cell Transplantation (32 papers). Stephen D. Nimer is often cited by papers focused on Acute Myeloid Leukemia Research (86 papers), Epigenetics and DNA Methylation (35 papers) and Hematopoietic Stem Cell Transplantation (32 papers). Stephen D. Nimer collaborates with scholars based in United States, China and Japan. Stephen D. Nimer's co-authors include Virginia M. Klimek, Craig H. Moskowitz, Andrew D. Zelenetz, Joachim Yahalom, Hideo Uchida, Piernicola Boccuni, Richard C. Frank, Tarun Kewalramani, Richard M. Stone and John M. Bennett and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Stephen D. Nimer

234 papers receiving 14.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decitabine improves patient outcomes in myelodysplastic syndromes

2006 1.1k citations Virginia M. Klimek, Stephen D. Nimer et al. profile →
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

2004 528 citations Virginia M. Klimek, Stephen D. Nimer et al. Blood profile →
Report of an international working group to standardize response criteria for myelodysplastic syndromes.

2000 524 citations Stephen D. Nimer et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen D. Nimer United States	64	7.5k	6.8k	3.4k	2.8k	2.4k	239	14.6k
Tomoki Naoe Japan	56	8.1k 1.1×	7.9k 1.2×	2.9k 0.9×	2.7k 1.0×	1.5k 0.6×	352	15.9k
Dolors Colomer Spain	60	5.1k 0.7×	2.7k 0.4×	3.1k 0.9×	4.9k 1.8×	4.4k 1.8×	280	12.0k
Francesco Lo‐Coco Italy	58	11.3k 1.5×	11.2k 1.7×	2.7k 0.8×	2.6k 0.9×	1.4k 0.6×	276	18.0k
D. Gary Gilliland United States	62	8.4k 1.1×	8.1k 1.2×	2.8k 0.8×	4.2k 1.5×	833 0.3×	126	16.2k
Bruno Quesnel France	47	3.5k 0.5×	3.6k 0.5×	2.6k 0.8×	1.9k 0.7×	1.2k 0.5×	202	8.1k
Justus Duyster Germany	52	3.9k 0.5×	3.5k 0.5×	2.4k 0.7×	2.2k 0.8×	1.3k 0.5×	261	9.0k
Ulrich Dührsen Germany	51	2.2k 0.3×	3.1k 0.5×	3.0k 0.9×	3.3k 1.2×	3.3k 1.3×	283	10.3k
Antonino Neri Italy	64	7.9k 1.1×	3.8k 0.6×	4.7k 1.4×	3.1k 1.1×	3.7k 1.5×	410	14.5k
Elisabeth Paietta United States	61	4.7k 0.6×	7.8k 1.2×	3.0k 0.9×	2.6k 0.9×	1.5k 0.6×	278	12.9k
Claus R. Bartram Germany	48	3.8k 0.5×	4.1k 0.6×	1.7k 0.5×	2.1k 0.8×	1.1k 0.4×	212	10.0k

Countries citing papers authored by Stephen D. Nimer

Since Specialization

Citations

This map shows the geographic impact of Stephen D. Nimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Nimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Nimer more than expected).

Fields of papers citing papers by Stephen D. Nimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Nimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Nimer. The network helps show where Stephen D. Nimer may publish in the future.

Co-authorship network of co-authors of Stephen D. Nimer

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. Nimer. A scholar is included among the top collaborators of Stephen D. Nimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. Nimer. Stephen D. Nimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Fan, Jingyin Yue, Francesco Tamiro, et al.. (2025). TAF1 is required for fetal but not adult hematopoiesis in mice. Developmental Cell. 60(21). 2946–2961.e8.

Tiniakou, Ioanna, Görkem Garipler, Nicholas M. Adams, et al.. (2024). Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation. Science Immunology. 9(94). eadi1023–eadi1023. 6 indexed citations

Ge, Guo, Peng Zhang, Ying Guo, et al.. (2023). Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models. Journal of Clinical Investigation. 134(1). 3 indexed citations

Guo, Ying, Guo Ge, Ganqian Zhu, et al.. (2023). Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping. EMBO Reports. 24(10). e57032–e57032. 14 indexed citations

Chen, Chuan, Na Man, Fan Liu, et al.. (2022). Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer. Cancer Research. 82(11). 2047–2056. 7 indexed citations

Sun, Jun, Gabriel Gaidosh, Ye Xu, et al.. (2021). RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells. Oncogene. 40(40). 5950–5962. 11 indexed citations

Man, Na, Xiao‐Jian Sun, Yurong Tan, et al.. (2016). Differential role of Id1 in MLL-AF9–driven leukemia based on cell of origin. Blood. 127(19). 2322–2326. 14 indexed citations

Shirakawa, Kotaro, Lan Wang, Na Man, et al.. (2016). Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity. eLife. 5. 55 indexed citations

Greenblatt, Sarah & Stephen D. Nimer. (2014). Chromatin modifiers and the promise of epigenetic therapy in acute leukemia. Leukemia. 28(7). 1396–1406. 57 indexed citations

10.

Landau, Heather, Samuel McNeely, Jayasree S. Nair, et al.. (2012). The Checkpoint Kinase Inhibitor AZD7762 Potentiates Chemotherapy-Induced Apoptosis of p53 -Mutated Multiple Myeloma Cells. Molecular Cancer Therapeutics. 11(8). 1781–1788. 48 indexed citations

11.

Sashida, Goro, Narae Bae, Silvana Di Giandomenico, et al.. (2011). The Mef/Elf4 Transcription Factor Fine Tunes the DNA Damage Response. Cancer Research. 71(14). 4857–4865. 12 indexed citations

12.

Hoya-Arias, Ruben, Mark Tomishima, Fabiana Perna, Francesca Voza, & Stephen D. Nimer. (2011). L3MBTL1 Deficiency Directs the Differentiation of Human Embryonic Stem Cells Toward Trophectoderm. Stem Cells and Development. 20(11). 1889–1900. 10 indexed citations

13.

Klimek, Virginia M., P. Maslak, Ilhem Guernah, et al.. (2008). Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes. Clinical Cancer Research. 14(3). 826–832. 113 indexed citations

14.

Morales, Mónica, Yan Liu, Evagelia C. Laiakis, et al.. (2008). DNA Damage Signaling in Hematopoietic Cells: A Role for Mre11 Complex Repair of Topoisomerase Lesions. Cancer Research. 68(7). 2186–2193. 16 indexed citations

15.

Lin, Ying-Wei, Mary Barbara, Norman N. Iscove, et al.. (2005). OLIG2 (BHLHB1), a bHLH Transcription Factor, Contributes to Leukemogenesis in Concert with LMO1. Cancer Research. 65(16). 7151–7158. 26 indexed citations

16.

MacGrogan, Donal, Sara Álvarez, Tony DeBlasio, Suresh C. Jhanwar, & Stephen D. Nimer. (2001). Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines. Oncogene. 20(31). 4150–4160. 28 indexed citations

17.

Mao, Shifeng, Richard C. Frank, Jin Zhang, Yasushi Miyazaki, & Stephen D. Nimer. (1999). Functional and Physical Interactions between AML1 Proteins and an ETS Protein, MEF: Implications for the Pathogenesis of t(8;21)-Positive Leukemias. Molecular and Cellular Biology. 19(5). 3635–3644. 112 indexed citations

18.

Greene, Mark E., Bruce Blumberg, O. Wesley McBride, et al.. (1995). Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.. Europe PMC (PubMed Central). 4(4-5). 281–99. 337 indexed citations

19.

Fraser, John K., et al.. (1994). Characterization of a Cell-Type-Restricted Negative Regulatory Activity of the Human Granulocyte-Macrophage Colony-Stimulating Factor Gene. Molecular and Cellular Biology. 14(3). 2213–2221. 4 indexed citations

20.

Champlin, Richard E., J Jansen, W. G. Ho, et al.. (1991). Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.. PubMed. 23(1 Pt 2). 1695–6. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact